传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2021 ASH指南：COVID-19患者应用抗凝剂进行血栓预防

2021-02-09 美国血液病学会 Blood Adv . 2021 Feb 9;5(3):872-888.

抗凝剂

2019年冠状病毒病（COVID-19）相关的重症和急性疾病与静脉血栓栓塞（VTE）风险相关。美国血液学会（ASH）发布本指南旨在支持患者、临床医生和其他卫生保健专业人员对COVID-19相关的危重症

中文标题：

2021 ASH指南：COVID-19患者应用抗凝剂进行血栓预防

英文标题：

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

发布机构：

美国血液病学会

发布日期：

2021-02-09

简要介绍：

2019年冠状病毒病（COVID-19）相关的重症和急性疾病与静脉血栓栓塞（VTE）风险相关。美国血液学会（ASH）发布本指南旨在支持患者、临床医生和其他卫生保健专业人员对COVID-19相关的危重症和急性病患者使用抗凝剂进行血栓预防的决策。

相关资料下载：
[AttachmentFileName(sort=1, fileName=患者应用抗凝剂进行血栓预.pdf)] GetToolGuiderByIdResponse(projectId=1, id=795141c0020e03ce, title=2021 ASH指南：COVID-19患者应用抗凝剂进行血栓预防, enTitle=American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19, guiderFrom=Blood Adv . 2021 Feb 9;5(3):872-888., authorId=0, author=, summary=2019年冠状病毒病（COVID-19）相关的重症和急性疾病与静脉血栓栓塞（VTE）风险相关。美国血液学会（ASH）发布本指南旨在支持患者、临床医生和其他卫生保健专业人员对COVID-19相关的危重症, cover=https://img.medsci.cn/2021313/1615649885293_2020535.jpg, journalId=0, articlesId=null, associationId=25, associationName=美国血液病学会, associationIntro=美国血液病学会---是全球最大的关于血液疾病病因及治疗的专业协会。其使命为通过促进血液学的研究、临床护理、教育、培训及宣传而进一步促进对血液、骨髓、免疫、凝血及脉管系统疾病的了解、诊断与防治。ASH的官方杂志为《血液》，是该领域被引用最多的同行评议杂志，周刊。, copyright=0, guiderPublishedTime=Tue Feb 09 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>2019年冠状病毒病（COVID-19）相关的重症和急性疾病与静脉血栓栓塞（VTE）风险相关。美国血液学会（ASH）发布本指南旨在支持患者、临床医生和其他卫生保健专业人员对COVID-19相关的危重症和急性病患者使用抗凝剂进行血栓预防的决策。</p>, tagList=[TagDto(tagId=819, tagName=抗凝剂)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=819, guiderKeyword=抗凝剂, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13080, appHits=87, showAppHits=0, pcHits=614, showPcHits=12993, likes=1, shares=9, comments=8, approvalStatus=1, publishedTime=Sat Mar 13 23:54:01 CST 2021, publishedTimeString=2021-02-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 13 23:38:18 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:03:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=患者应用抗凝剂进行血栓预.pdf)])
患者应用抗凝剂进行血栓预.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1063746, encodeId=cafb1063e4680, content=有中文版下载吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58005647136, createdName=ms7000000878022419, createdTime=Mon Oct 25 12:54:36 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975520, encodeId=622f9e5520d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25f35500181, createdName=超及宝宝, createdTime=Mon Jun 21 17:25:04 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958793, encodeId=d093958e938c, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958443, encodeId=f0079584436c, content=好指力南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 19 18:37:42 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950326, encodeId=bad9950326fc, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca375472317, createdName=ms7000002063729446, createdTime=Tue Mar 23 12:20:26 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-10-25 ms7000000878022419

    有中文版下载吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1063746, encodeId=cafb1063e4680, content=有中文版下载吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58005647136, createdName=ms7000000878022419, createdTime=Mon Oct 25 12:54:36 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975520, encodeId=622f9e5520d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25f35500181, createdName=超及宝宝, createdTime=Mon Jun 21 17:25:04 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958793, encodeId=d093958e938c, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958443, encodeId=f0079584436c, content=好指力南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 19 18:37:42 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950326, encodeId=bad9950326fc, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca375472317, createdName=ms7000002063729446, createdTime=Tue Mar 23 12:20:26 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-06-21 超及宝宝

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1063746, encodeId=cafb1063e4680, content=有中文版下载吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58005647136, createdName=ms7000000878022419, createdTime=Mon Oct 25 12:54:36 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975520, encodeId=622f9e5520d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25f35500181, createdName=超及宝宝, createdTime=Mon Jun 21 17:25:04 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958793, encodeId=d093958e938c, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958443, encodeId=f0079584436c, content=好指力南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 19 18:37:42 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950326, encodeId=bad9950326fc, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca375472317, createdName=ms7000002063729446, createdTime=Tue Mar 23 12:20:26 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-04-20 jyzxjiangqin

    好指南！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1063746, encodeId=cafb1063e4680, content=有中文版下载吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58005647136, createdName=ms7000000878022419, createdTime=Mon Oct 25 12:54:36 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975520, encodeId=622f9e5520d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25f35500181, createdName=超及宝宝, createdTime=Mon Jun 21 17:25:04 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958793, encodeId=d093958e938c, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958443, encodeId=f0079584436c, content=好指力南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 19 18:37:42 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950326, encodeId=bad9950326fc, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca375472317, createdName=ms7000002063729446, createdTime=Tue Mar 23 12:20:26 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-04-19 jyzxjiangqin

    好指力南！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1063746, encodeId=cafb1063e4680, content=有中文版下载吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58005647136, createdName=ms7000000878022419, createdTime=Mon Oct 25 12:54:36 CST 2021, time=2021-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975520, encodeId=622f9e5520d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25f35500181, createdName=超及宝宝, createdTime=Mon Jun 21 17:25:04 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958793, encodeId=d093958e938c, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:17 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958443, encodeId=f0079584436c, content=好指力南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Apr 19 18:37:42 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950326, encodeId=bad9950326fc, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca375472317, createdName=ms7000002063729446, createdTime=Tue Mar 23 12:20:26 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-03-23 ms7000002063729446

    好指南

    0

相关指南

2016 EHRA实用指南：应用非维生素K拮抗剂类口服抗凝剂治疗非瓣膜性房颤患者（更新）

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2016-06-09

拓展阅读

2016 EHRA实用指南：应用非维生素K拮抗剂类口服抗凝剂治疗非瓣膜性房颤患者（更新）

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2016-06-09

关于慢性肾脏病患者新型口服抗凝剂的安全性/有效性特征的立场文件

意大利肾病学会(SIN,Italian Society of Nephrology) · 2021-11-01

2021 ASH 生活指南更新：在 COVID-19 患者中使用抗凝剂预防血栓

美国血液病学会(ASH,American Society of Hematology) · 2022-01-25